Ladenburg Thalmann Financial Services’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | $232K | Buy |
3,549
+1,823
| +106% | +$119K | ﹤0.01% | 2391 |
|
|
2019
Q3 | $107K | Buy |
1,726
+412
| +31% | +$25.5K | ﹤0.01% | 2884 |
|
|
2019
Q2 | $95K | Buy |
1,314
+250
| +23% | +$18.1K | ﹤0.01% | 3004 |
|
|
2019
Q1 | $84K | Buy |
1,064
+61
| +6% | +$4.82K | ﹤0.01% | 3011 |
|
|
2018
Q4 | $84K | Buy |
1,003
+668
| +199% | +$55.9K | ﹤0.01% | 2875 |
|
|
2018
Q3 | $58K | Sell |
335
-438
| -57% | -$75.8K | ﹤0.01% | 3208 |
|
|
2018
Q2 | $79K | Hold |
773
| – | – | ﹤0.01% | 2920 |
|
|
2018
Q1 | $79K | Sell |
773
-1
| -0.1% | -$102 | ﹤0.01% | 2920 |
|
|
2017
Q4 | $67K | Buy |
774
+107
| +16% | +$9.26K | ﹤0.01% | 3023 |
|
|
2017
Q3 | $57K | Sell |
667
-67
| -9% | -$5.73K | ﹤0.01% | 2993 |
|
|
2017
Q2 | $56K | Sell |
734
-63
| -8% | -$4.81K | ﹤0.01% | 2944 |
|
|
2017
Q1 | $53K | Buy |
797
+10
| +1% | +$665 | ﹤0.01% | 2860 |
|
|
2016
Q4 | $51K | Buy |
787
+141
| +22% | +$9.14K | ﹤0.01% | 2833 |
|
|
2016
Q3 | $42K | Sell |
646
-1,015
| -61% | -$66K | ﹤0.01% | 2908 |
|
|
2016
Q2 | $125K | Buy |
1,661
+874
| +111% | +$65.8K | ﹤0.01% | 1994 |
|
|
2016
Q1 | $53K | Sell |
787
-451
| -36% | -$30.4K | ﹤0.01% | 2551 |
|
|
2015
Q4 | $84K | Sell |
1,238
-5,775
| -82% | -$392K | ﹤0.01% | 2188 |
|
|
2015
Q3 | $374K | Buy |
7,013
+2,366
| +51% | +$126K | 0.01% | 1120 |
|
|
2015
Q2 | $293K | Buy |
4,647
+3,897
| +520% | +$246K | 0.01% | 1350 |
|
|
2015
Q1 | $36K | Buy |
750
+195
| +35% | +$9.36K | ﹤0.01% | 2799 |
|
|
2014
Q4 | $18K | Sell |
555
-596
| -52% | -$19.3K | ﹤0.01% | 3057 |
|
|
2014
Q3 | $34K | Buy |
1,151
+1,122
| +3,869% | +$33.1K | ﹤0.01% | 2271 |
|
|
2014
Q2 | $1K | Buy |
+29
| New | +$1K | ﹤0.01% | 3765 |
|
|
2014
Q1 | – | Sell |
-321
| Closed | -$11K | – | 3807 |
|
|
2013
Q4 | $11K | Buy |
+321
| New | +$11K | ﹤0.01% | 2883 |
|